BPBruno Pitard

Bruno Pitard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bruno Pitard has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Denis Escande

    L'Institut du Thorax, Institut National de la Santé et de la Recherche Médicale, Inserm U533, Faculté de Médecine, 44000 Nantes, France

    3 shared publications
  • Hélène Pollard

    L'Institut du Thorax, Institut National de la Santé et de la Recherche Médicale, Inserm U533, Faculté de Médecine, 44000 Nantes, France

    3 shared publications
  • Olivier Lambert

    L'institut du Thorax, Inserm U533, Faculté de Médecine, 44035 Nantes, France, 1IECB-UBS UMR CNRS 5471 CNRS, Université Bordeaux 1, avenue des Facultés, 33405 Talence, France, 2Université Paris XI, 91400 Orsay, France and 3INRA-SCRIBE, Campus Beaulieu, 35042 Rennes, France

    3 shared publications
  • Caroline Lanctin

    L'Institut du Thorax, Institut National de la Santé et de la Recherche Médicale, Inserm U533, Faculté de Médecine, 44000 Nantes, France

    2 shared publications
  • Jean-Louis Rigaud

    CNRS UMR 168 and CEA LRC, Institut Curie, 75005 Paris, France

    2 shared publications
  • Peggy Richard

    L'Institut du Thorax, Institut National de la Santé et de la Recherche Médicale, Inserm U533, Faculté de Médecine, 44000 Nantes, France

    2 shared publications

Latest Publications

  • Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation

    by Peggy Richard, Hélène Pollard, Caroline Lanctin, Mahajoub Bello‐Roufaï, Léa Désigaux, Denis Escande, Bruno Pitard

    Background: We have previously shown that intramuscular injection of plasmid DNA formulated with a non‐ionic amphiphile synthetic vector [poly(ethylene oxide)13‐poly(propylene oxide)30‐poly(ethylene oxide)13 block copolymer; PE6400] increases reporter gene expression compared with naked DNA. We have now investigated this simple non‐viral formulation for production of secreted proteins from the mouse skeletal muscle.Methods: Plasmids encoding either constitutive human secreted alkaline phosphatase or murine erythropoietin inducible via a Tet‐on system were formulated with PE6400 and intramuscularly injected into the mouse tibial anterior muscle.Results: PE6400/DNA formulation led to an increased amount of recombinant alkaline phosphatase secreted from skeletal muscle as compared with naked DNA. In the presence of doxycycline, a single injection of 10µg plasmid encoding inducible murine erythropoietin formulated with PE6400 significantly increased the hematocrit, whereas the same amount of DNA in the absence of PE6400 had no effect. The increase in the hematocrit was stable for 42 days. The tetracycline‐inducible promoter permitted pharmacological control of hematocrit level after DNA intramuscular injection. However, 4 months post‐injection the hematocrit returned to its pre‐injection value, even in the presence of doxycycline. This phenomenon was likely caused by an immune response against the tetracycline‐activated transcription factor.Conclusions: Intramuscular injection of plasmid DNA formulated with PE6400 provides an efficient and simple method for secretion and production of non‐muscle proteins. Copyright © 2004 John Wiley & Sons, Ltd.


  • Open Access

    Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer

    by Bruno Pitard, Mahajoub Bello-Roufaï, Olivier Lambert, Peggy Richard, Léa Desigaux, Sarah Fernandes, Caroline Lanctin, Hélène Pollard, Mehdi Zeghal, Pierre-Yves Rescan, et al.

    Over the past decade, numerous nonviral cationic vectors have been synthesized. They share a high density of positive charges and efficiency for gene transfer in vitro. However, their positively charged surface causes instability in body fluids and cytotoxicity, thereby limiting their efficacy in vivo. Therefore, there is a need for developing alternative molecular structures. We have examined tetrabranched amphiphilic block copolymers consisting of four polyethyleneoxide/polypropyleneoxide blocks centered on an ethylenediamine moiety. Cryo-electron microscopy, ethidium bromide fluorescence and light and X-ray scattering experiments performed on vector–DNA complexes showed that the dense core of the nanosphere consisted of condensed DNA interacting with poloxamine molecules through electrostatic, hydrogen bonding and hydrophobic interactions, with DNA molecules also being exposed at the surface. The supramolecular organization of block copolymer/DNA nanospheres induced the formation of negatively charged particles. These particles were stable in a solution that had a physiological ionic composition and were resistant to decomplexation by heparin. The new nanostructured material, the structure of which clearly contrasted with that of lipoplexes and polyplexes, efficiently transferred reporter and therapeutic genes in skeletal and heart muscle in vivo. Negatively charged supramolecular assemblies hold promise as therapeutic gene carriers for skeletal and heart muscle-related diseases and expression of therapeutic proteins for local or systemic uses.


  • A Nonionic Amphiphile Agent Promotes Gene Delivery In Vivo to Skeletal and Cardiac Muscles

    by Bruno Pitard, Hélène Pollard, Onnik Agbulut, Olivier Lambert, Jean-Thomas Vilquin, Yan Cherel, Jérôme Abadie, Jane-Lise Samuel, Jean-Louis Rigaud, Severine Menoret, et al.

    Direct injection of naked DNA into skeletal or cardiac muscle induces detectable gene expression. Although this provides a practical system for transgene expression, the reported efficacy is too low to confer a therapeutic benefit. By following a rational strategy based on the supramolecular structures adopted by active complexes, we have discovered a novel nonionic amphiphile synthetic agent [poly(ethyleneoxide)13-poly(propyleneoxide)30-poly(ethyleneoxide)13 block copolymer; PE6400] that enables gene expression in up to 35% of muscle fibers from mouse tibial cranial muscle. PE6400 abolishes the ceiling effect on transgene expression of increasing amounts of naked DNA and permits long-term expression of the β-galactosidase reporter gene in immunologically tolerant transgenic rats. This improvement in gene expression over naked DNA was observed irrespective of the reporter gene, ranging from 0.7 to 3.4 kb, and of the animal model used. In skeletal muscle, the PE6400 formulation led to a level of transfection efficiency similar to that obtained by electrotransfer. PE6400 also promotes high transgene expression in cardiac muscle. In contrast, PE6400-DNA formulations were inefficient in vitro in established cell lines and in isolated cardiomyocytes. When microinjected into the cell cytoplasm, PE6400 promotes DNA trafficking into the nucleus and induces gene expression. PE6400 provides a simple gene delivery system for skeletal and myocardial gene transfer. We propose that the PE6400 formulation could serve for the treatment of diseases primarily affecting muscle or for the expression of therapeutic proteins for local or systemic benefit.


  • Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airwaysin vivo

    by Bruno Pitard, Noufissa Oudrhiri, Olivier Lambert, Eric Vivien, Christophe Masson, Barbara Wetzer, Michelle Hauchecorne, Daniel Scherman, Jean-Louis Rigaud, Jean-Pierre Vigneron, et al.

    Background Colloidal stability of lipid/DNA aggregates is a major requirement for cationic lipid-mediated transfection which is particularly difficult to fulfil at the high DNA concentrations used for in vivo gene delivery. Thus, we have investigated the potential of poly(ethyleneglycol) (PEG) conjugates for steric stabilization of lipoplexes formed by bis(guanidinium)-tren-cholesterol/dioleoyl phosphatidylethanolamine (BGTC/DOPE) liposomes, a class of cationic liposomes we have developed over the past few years. Methods and results We demonstrate that adequate lipophilic PEG derivatives can stabilize BGTC/DOPE lipoplexes formed at high DNA concentration. We also report the results of cryotransmission electron microscopy studies indicating that PEG-stabilized lipoplexes form DNA-coated structures which assemble into clusters exhibiting various complex morphologies. Finally, we report data from in vivo transfection experiments suggesting that PEG-mediated colloidal stabilization of concentrated lipoplex solutions may allow enhanced transfection of the mouse airways via intranasal administration. Conclusion Our results represent an important step towards the design of multimodular BGTC-based systems for improved in vivo gene transfection. Copyright © 2001 John Wiley & Sons, Ltd.